INBS Intelligent Bio Solutions Inc.
Healthcare$2.57-2.28%ClosedMarket Cap: $1.7M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.46
P/S
0.42
EV/EBITDA
0.32
DCF Value
$0.37
FCF Yield
-689.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
32.1%
Operating Margin
-300.3%
Net Margin
-296.8%
ROE
-174.2%
ROA
-78.1%
ROIC
-110.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $1.1M | 23.1% | $-3.1M | $-2.9M | $— | — |
| Q2 null | $896.8K | 51.3% | $-2.6M | $-2.7M | $— | — |
| Q1 null | $1.1M | 19.3% | $-2.9M | $-3.0M | $— | — |
| Q4 null | $843.9K | 39.8% | $-3.1M | $-3.1M | $— | — |
| FY null | $3.1M | 40.8% | $-10.6M | $-10.6M | $— | — |
| Q3 null | $728.9K | 5.4% | $-2.7M | $-2.5M | $— | — |
| Q2 null | $607.5K | 36.7% | $-2.3M | $-2.2M | $— | — |
| Q1 null | $872.3K | 5.3% | $-2.9M | $-2.7M | $— | — |
| Q4 null | $727.8K | 112.1% | $-2.8M | $-2.8M | $— | — |
| FY null | $3.1M | 45.8% | $-10.3M | $-10.2M | $— | — |
| Q3 null | $823.8K | 21.7% | $-3.0M | $-3.0M | $— | — |
| Q2 2024 | $764.1K | 26.1% | $-2.0M | $-2.0M | $-20.70 | — |